Division of Renal Diseases and Hypertension
HOME
OUR FACILITIES
RESEARCH
MAKE A CLINIC APPOINTMENT
CALENDAR
FACULTY
FELLOWSHIP PROGRAM
MICROSCOPY CORE
EMPLOYEE LINKS
USEFUL LINKS

The Division of Renal Diseases and Hypertension has an exceptional faculty with over 20 NIH funded grants, placing the Division in the top ten in the country for research funding.

Research projects are listed below:

 

 

Polycystic kidney disease (PKD)

mTOR signaling in experimental models of polycystic kidney disease (Charles Edelstein)

Epidemiology and Genetics (Berenice Gitomer)

HALT trial (Robert Schrier)

TEMPO (Tolvaptan Efficacy and safety in Management of Polycystic kidney disease and its Outcomes) Phase 2 and 3 (Charles Edelstein)

Clinical trials in children with PKD (Melissa Cadnapornchai, Robert Schrier)

 

Acute Kidney injury (AKI)

Pathogenesis of septic AKI (Robert Schrier)

Pathogenesis of ischemic and cisplatin-induced AKI (Charles Edelstein)

Complement system in ischemic AKI (Joshua Thurman)

Systemic manifestations of AKI (Sarah Faubel)

Organ preservation and effects of hibernation on kidney function (Alkesh Jani, Charles Edelstein)

Biomarkers of acute kidney injury in cardiac and liver transplant patients (Charles Edelstein)

 

Chronic kidney disease (CKD)

Chronic Kidney Disease and Vitamin D metabolism (M Chonchol, D Spiegel)

Progression of Kidney Disease (Tomas Berl and Michel Chonchol)

Cardiovascular disease and mineral-bone disorders (Michel Chonchol)

 

Renal metabolism

Low fructose diet to reduce metabolic syndrome (Diana Jalal)

Fructose in kidney disease and metabolic syndrome (Taka Nakagawa, Chris Rivard, Richard Johnson)

Lipids and renal disease (Moshe Levi)

Reguation of phosphate transport (Moshe Levi)

 

Hypertension

Uric acid in the pathogenesis of hypertension and kidney disease (Taka Nakagawa,  Richard Johnson)

Pathogenesis of essential hypertension (Richard Johnson, Taka Nakagawa, Raphael Nemenoff)

Models of vascular injury (Seth Ferguson, Mary Weiser-Evans)

Transplantation

Various clinical trials in renal transplant patients (james Cooper Alexander  Wiseman and Larry Chan)

Biomarkers of delayed graft function in pigs and humans (Alkesh Jani, Charles Edelstein)

Biology of transplant rejection (Wiseman)

Application of NMR and other molecular biomarkers in allograft rejection (Larry Chan)

 

Glomerulonephritis

Minimal change disease (Richard Johnson, Gabriela Garcia)

Experimental models of glomerulonephritis (Richard Johnson, Gabriela Garcia)

 

Diabetic nephropathy

Animal models of diabetic nephropathy (Moshe Levi)

Pathogenesis and prevention of renal disease in diabetes, obesity, and aging (Tao Jiang, Moshe Levi)

Diabetic Nephropathy: pathogenesis and treatment (Taka Nakagawa, Richard Johnson, Moshe Levi)

Risk factors for hypertension, metabolic syndrome and diabetes (Diana Jalal,  Michel  Chonchol)

Collaborative study group (Tomas Berl)

 

Basic

Membrane trafficking in renal tubular cells (Judy Blaine)

Genetic mouse models of disease (Raphael Nemenoff, Mary Weiser-Evans)

Cellular and molecular biology of hormone signaling (Raphael Nemenoff, Mary Weiser-Evans)

Vasopressin and aquaporin biology (Robert Schrier, Tomas Berl )

Pathways controlling progression and metastasis of cancer (Raphael Nemenoff)

Response of vascular smooth muscle cells to injury (Raphael Nemenoff)

 

Medical informatics (David Spiegel)

 

Microscopy Core: Advanced microscopy core that provides state of the art confocal microscopy and intravital microscopy for the imaging of cellular and subcellular structures (see Microscopy Core)

 

Renal Clinical Trials Office

Various pharmaceutical company and NIH-funded clinical trials

Janis Cicerchi (Head), Andrea Singleton, Lois Clegg, Kathy Duncan, Ann Cline, Eric Harvester

 

 

 

 

 

 



[UCHSC Branding]       University of Colorado Denver (UCD)       Search UCD and Affiliates
University of Colorado Hospital (UCH) UCD Newsroom
This site last updated on 10-19-09